logo

For the Inventor, By the Inventor

Dublin, CA, United States of America

Jeri D Wright

This inventor holds 20 USPTO granted patents, primarily in Osmotic Drug Delivery. Top assignees: Alza Corporation, Other. Active years: 1990-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeri D Wright. Retrieved from https://idiyas.com/inventor/jeri-d-wright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 90.0

Average Co-Inventor Count = 5.0

ph-index = 15

Forward Citations = 1,054(Granted Patents)


Location History:

  • Dublin, CA (US) (1990 - 2015)
  • Palo Alto, CA (US) (2015)

Company Filing History:

goldMedal19 out of 1,062 
 
Alza Corporation
 patents
silverMedal1 out of 834,601 
Other
 patents

Years Active: 1990-2015

Loading Chart...
Areas of Expertise:
Osmotic Device
Drug Therapy
Hydrogel
Fertility Control
Therapeutic Composition
Dosage Forms
Polymer
Nystatin
Cardiovascular Treatment
Contraceptive Pill
Delayed Activation
High Drug Loading
20 patents (USPTO):Explore Patents
1. 9029416 - Methods and devices for providing prolonged drug therapy (2015-05-12),
2. 9000038 - Methods and devices for providing prolonged drug therapy (2015-04-07),
3. 6930129 - Methods and devices for providing prolonged drug therapy (2005-08-16),
4. 6919373 - Methods and devices for providing prolonged drug therapy (2005-07-19),
5. 5869096 - Oral osmotic device with hydrogel driving member (1999-02-09),
6. 5842476 - Method for controlling fertility (1998-12-01),
7. 5817335 - Osmotic device with high drug loading and delayed activation of drug (1998-10-06),
8. 5776493 - Oral osmotic device for delivery of nystatin with hydrogel driving member (1998-07-07),
9. 5595759 - Process for providing therapeutic composition (1997-01-21),
10. 5573776 - Oral osmotic device with hydrogel driving member (1996-11-12),
11. 5326571 - Dosage forms comprising polymers comprising different molecular weights (1994-07-05),
12. 5248310 - Oral osmotic device with hydrogel driving member (1993-09-28),
13. 5208037 - Dosage forms comprising polymers comprising different molecular weights (1993-05-04),
14. 5200197 - Contraceptive pill (1993-04-06),
15. 5098714 - Osmotic, oral dosage form for fertility control (1992-03-24),

Title: **Jeri D Wright: Innovator in Prolonged Drug Therapy**

Introduction

Jeri D Wright, based in Dublin, California, is a prolific inventor known for his contributions to pharmaceutical technology, holding an impressive portfolio of 20 patents. His work primarily focuses on developing methods and devices that enhance therapeutic drug delivery, ultimately improving patient outcomes.

Latest Patents

Among his notable patents, Jeri has pioneered methods and devices for providing prolonged drug therapy. These innovations ensure a desired therapeutic drug effect is maintained over extended periods. Specifically, he has developed oral dosage forms that release medication within the gastrointestinal tract at an ascending release rate, which enhances the efficacy of long-term treatments. These dosage forms may also include an immediate-release dose of the drug, providing flexibility in medication administration.

Career Highlights

Throughout his career, Jeri has made significant contributions while working with prominent organizations like Alza Corporation. His work at Alza and other firms has established him as a key player in the field of drug delivery systems, showcasing his commitment to advancing pharmaceutical technologies.

Collaborations

Jeri has collaborated with talented professionals in the industry, including coworkers Brian L Barclay and Patrick S Wong. These collaborations have contributed to the innovative approaches he employs in his research and development efforts, further solidifying his reputation as a leading inventor.

Conclusion

With a solid foundation of patents and a track record of impactful innovations, Jeri D Wright continues to advance the field of prolonged drug therapy. His dedication to enhancing therapeutic strategies through creative solutions exemplifies his significant role in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…